血府逐瘀胶囊治疗急性附睾炎的疗效观察  

Observation on Efficacy of Xuefuzhuyu Capsules in Treatment of Acute Epididymitis

作　　者：黄慧[1] 潘晖[1] 钟光俊[1] 成少平[1] 刘昌茂[1] 周章炎[1] 

机构地区：[1]荆州市第一人民医院泌尿外科,湖北荆州434000

出　　处：《中国医院用药评价与分析》2016年第8期1048-1050,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨血府逐瘀胶囊联合抗菌药物及地塞米松治疗急性附睾炎的临床疗效。方法:选取2014年6月—2016年1月荆州市第一人民医院收治的急性附睾炎患者120例,以随机数字表法分为观察组和对照组各60例。对照组患者给予抗菌药物和地塞米松治疗,观察组患者在对照组的基础上联合血府逐瘀胶囊治疗,比较2组的临床疗效。结果:观察组的总有效率为93.3%(56/60),对照组为73.3%(44/60);观察组患者的附睾结节遗留率为3.3%(2/60),对照组为16.7%(10/60),2组的差异均有统计学意义(P<0.05)。结论:在有效抗感染治疗的基础上,早期应用地塞米松联合血府逐瘀胶囊治疗急性附睾炎,可显著提高疗效,降低附睾结节遗留率。OBJECTIVE：To probe into the clinical efficacy of Xuefuzhuyu capsules combined with antibiotics and dexamethasone in treatment of acute epididymitis. METHODS： 120 patients with acute cpididymitis admitted into Jingzhou the First People＇s Hospital from Jun. 2014 to Jan. 2016 were selected to be divided into observation group and control group via the random number table, with 60 cases in each. The control group were treated with antibiotics and dexamethasone, while the observation group additionally received Xuefuzhuyu capsules based on the control group. The clinical efficacy were compared between two groups. RESULTS： The total effective rate of observation group was 93.3% （56/60）, and control group was 73.3% （44/60）. The epididymal callosity rates of observation group and control group were respectively 3.3% （2/60）and 16.7% （10/60）, with statistically significant difference （P 〈 0.05 ）. CONCLUSIONS： Based on the effective anti-infective therapy, early application of dexamethasone combined with Xuefuzhuyu capsules can significantly improve the curative effects and reduce the epididymal callosity rate.

关 键 词：血府逐瘀胶囊 抗菌药物 地塞米松 急性附睾炎 中西医结合 

分 类 号：R983[医药卫生—药品]